Attached files

file filename
EX-10.2 - EXHIBIT 10.2 - Spring Creek Healthcare Systems, Inc.ex102.htm
EX-10.1 - EXHIBIT 10.1 - Spring Creek Healthcare Systems, Inc.ex101.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
May 4, 2011
 
Date of Report (Date of earliest event reported)
 
SPRING CREEK HEALTHCARE SYSTEMS, INC.
 
(Exact name of registrant as specified in its charter)
 
Nevada
814-00783
98-0496750
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

 
120 Wall Street, 24th Floor
New York, NY
10005
(Address of principal executive offices)
(Zip Code)
   

(646) 896-3050
Registrant's telephone number, including area code
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
____ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
____ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
 
____ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
 
____ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
 
 
1

 
 
Section 5 - Corporate Governance and Management
 
Item 5.02 -  Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
On May 4, 2011, the Board of Directors adopted the 2011 Employee, Director and Consultant Incentive Plan and the 2011 Board Compensation Plan.

Item 9.01. Financial Statements and Exhibits.
 
(d)
Exhibits.
 
10.1 
2011 Employee, Director and Consultant Incentive Plan
10.2 
2011 Board Compensation Plan

 
2

 

SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  THERABIOGEN, INC  
       
Date: May 10, 2011
By:
/s/ Kelly T. Hickel  
    Kelly T. Hickel  
    Chief Executive Officer  
       
 
 
 

3